Literature DB >> 12094539

Breast cancer in HIV-positive women: a report of four cases and review of the literature.

Ioannis A Voutsadakis1, Lewis R Silverman.   

Abstract

Only 16 cases of breast carcinoma in human immunodeficiency virus (HIV) seropositive patients have been reported in the literature. We report four cases of breast cancer in women seropositive for the HIV and review the literature. Breast cancer is not an acquired immunodeficiency syndrome (AIDS)-defining disease and its incidence is not increased in HIV patients. Most patients reported had a CD4 count, which was above the threshold considered critical for significant immunosuppression suggesting that, HIV related immunocompromise does not have a direct tumorigenic role. Alternatively, the biology of breast cancer appears to be more aggressive in HIV-positive women suggesting a permissive role of the virus in the progression of the cancer. The aggressiveness of the breast carcinoma in HIV-positive women justifies every effort to preserve the dose intensity of treatment in those patients, especially in the current era of more effective HIV treatment which leads to improved survival.

Entities:  

Mesh:

Year:  2002        PMID: 12094539     DOI: 10.1081/cnv-120002144

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  8 in total

Review 1.  Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary?

Authors:  Nadine Housri; Robert Yarchoan; Aradhana Kaushal
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

Review 2.  Screening HIV-infected patients for non-AIDS-defining malignancies.

Authors:  Adrienne A Phillips; Jessica E Justman
Journal:  Curr HIV/AIDS Rep       Date:  2009-05       Impact factor: 5.071

3.  Micrometastasis of papillary thyroid carcinoma in a human immunodeficiency virus-infected patient: a case report and discussion.

Authors:  Célia Lloret Linares; Didier Troisvallets; Pierre Sellier; André Aurengo; Laurence Leenhardt
Journal:  Med Oncol       Date:  2009-08-06       Impact factor: 3.064

4.  Phenotype and Treatment of Breast Cancer in HIV-Positive and -Negative Women in Cape Town, South Africa.

Authors:  Lizanne Langenhoven; Pieter Barnardt; Alfred I Neugut; Judith S Jacobson
Journal:  J Glob Oncol       Date:  2016-03-30

5.  Breast cancer, human immunodeficiency virus and highly active antiretroviral treatment; implications for a high-rate seropositive region.

Authors:  Subash Chirkut
Journal:  Oncol Rev       Date:  2019-01-14

6.  HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness.

Authors:  Francesca Caccuri; Francesca Giordano; Ines Barone; Pietro Mazzuca; Cinzia Giagulli; Sebastiano Andò; Arnaldo Caruso; Stefania Marsico
Journal:  Infect Agent Cancer       Date:  2017-09-25       Impact factor: 2.965

Review 7.  Breast Cancer and HIV in Sub-Saharan Africa: A Complex Relationship.

Authors:  Surbhi Grover; Yehoda M Martei; Priya Puri; Pooja Prabhakar; Miriam Mutebi; Onyinye D Balogun; Aryeh J Price; Alexandra H Freeman; Mohan Narasimhamurthy; Danielle Rodin; Sarah Rayne; Nicola M Zetola
Journal:  J Glob Oncol       Date:  2017-01-11

8.  Association between HIV infection and outcomes of care among medicare enrollees with breast cancer.

Authors:  Sumedha Chhatre; Marilyn Schapira; David S Metzger; Ravishankar Jayadevappa
Journal:  EClinicalMedicine       Date:  2019-11-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.